Camrelizumab combined with Apatinib in the treatment of patients with advanced gastric cancer and colorectal cancer: single arm exploratory study

ABSTRACT: Interventions: Case series:Camrelizumab + Apatinib Primary outcome(s): Objective response rate Study Design: Single arm

DISEASE(S): Gastric Cancer Or Colorectal Cancer

PROVIDER: 2686078 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR